Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.8071 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.75528 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7581 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.69486 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.69156 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.83141 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.88164 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.73052 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.71925 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74057 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.73951 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.72012 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.74805 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.74545 | 33 |